These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 31699735)

  • 21. Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty.
    Anderson DR; Dunbar M; Murnaghan J; Kahn SR; Gross P; Forsythe M; Pelet S; Fisher W; Belzile E; Dolan S; Crowther M; Bohm E; MacDonald SJ; Gofton W; Kim P; Zukor D; Pleasance S; Andreou P; Doucette S; Theriault C; Abianui A; Carrier M; Kovacs MJ; Rodger MA; Coyle D; Wells PS; Vendittoli PA
    N Engl J Med; 2018 Feb; 378(8):699-707. PubMed ID: 29466159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative Effectiveness and Safety of Drug Prophylaxis for Prevention of Venous Thromboembolism After Total Knee Arthroplasty.
    Cafri G; Paxton EW; Chen Y; Cheetham CT; Gould MK; Sluggett J; Bini SA; Khatod M
    J Arthroplasty; 2017 Nov; 32(11):3524-3528.e1. PubMed ID: 28634095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Effectiveness of Aspirin as Multimodal Thromboprophylaxis in Primary Total Hip and Knee Arthroplasty: A Review of 6078 Cases.
    Ghosh A; Best AJ; Rudge SJ; Chatterji U
    J Arthroplasty; 2019 Jul; 34(7):1359-1363. PubMed ID: 30982759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Case-control study on three antithrombotic agents for the prevention of venous thromboembolism after unilateral total knee arthroplasty].
    Miao SG; Zhang XG; Lu JH; Yang Y; Lu N
    Zhongguo Gu Shang; 2015 Oct; 28(10):893-6. PubMed ID: 26727779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative effectiveness of aspirin for symptomatic venous thromboembolism prophylaxis in patients undergoing total joint arthroplasty, a cohort study.
    Sidhu V; Badge H; Churches T; Maree Naylor J; Adie S; A Harris I
    BMC Musculoskelet Disord; 2023 Aug; 24(1):629. PubMed ID: 37537580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aspirin compared to enoxaparin or rivaroxaban for thromboprophylaxis following hip and knee replacement.
    Ní Cheallaigh S; Fleming A; Dahly D; Kehoe E; O'Byrne JM; McGrath B; O'Connell C; Sahm LJ
    Int J Clin Pharm; 2020 Jun; 42(3):853-860. PubMed ID: 32328957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of symptomatic venous thromboembolism in 2372 knee and hip replacement patients after discharge: data from a thromboprophylaxis registry in Montreal, Canada.
    Senay A; Trottier M; Delisle J; Banica A; Benoit B; Laflamme GY; Malo M; Nguyen H; Ranger P; Fernandes JC
    Vasc Health Risk Manag; 2018; 14():81-89. PubMed ID: 29780248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factor Xa Inhibitors and Direct Thrombin Inhibitors Versus Low-Molecular-Weight Heparin for Thromboprophylaxis After Total Hip or Total Knee Arthroplasty: A Systematic Review and Meta-Analysis.
    Sun G; Wu J; Wang Q; Liang Q; Jia J; Cheng K; Sun G; Wang Z
    J Arthroplasty; 2019 Apr; 34(4):789-800.e6. PubMed ID: 30685261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological thromboprophylaxis and its impact on venous thromboembolism following total knee and hip arthroplasty in Korea: A nationwide population-based study.
    Yhim HY; Lee J; Lee JY; Lee JO; Bang SM
    PLoS One; 2017; 12(5):e0178214. PubMed ID: 28542415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low molecular weight heparin versus other anti-thrombotic agents for prevention of venous thromboembolic events after total hip or total knee replacement surgery: a systematic review and meta-analysis.
    Lu X; Lin J
    BMC Musculoskelet Disord; 2018 Sep; 19(1):322. PubMed ID: 30193575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does the form of venous thromboembolism prophylaxis following primary total knee arthroplasty alter the rate of early reoperation or revision surgery?
    Kerr DL; Butler S; Read AC; Harris IA
    ANZ J Surg; 2019 Oct; 89(10):1211-1216. PubMed ID: 31234237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bleeding and thromboembolism risk of standard antithrombotic prophylaxis after hip or knee replacement within an enhanced recovery program.
    Jenny JY; Bulaid Y; Boisrenoult P; Bonin N; Henky P; Tracol P; Chouteau J; Courtin C; Henry MP; Schwartz C; Mertl P; De Ladoucette A;
    Orthop Traumatol Surg Res; 2020 Dec; 106(8):1533-1538. PubMed ID: 33127330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial.
    Camporese G; Bernardi E; Prandoni P; Noventa F; Verlato F; Simioni P; Ntita K; Salmistraro G; Frangos C; Rossi F; Cordova R; Franz F; Zucchetta P; Kontothanassis D; Andreozzi GM;
    Ann Intern Med; 2008 Jul; 149(2):73-82. PubMed ID: 18626046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The efficacy of aspirin versus low-molecular-weight heparin for venous thromboembolism prophylaxis after knee and hip arthroplasty: A systematic review and meta-analysis of randomized controlled trials.
    Salman LA; Altahtamouni SB; Khatkar H; Al-Ani A; Hameed S; Alvand A
    Knee Surg Sports Traumatol Arthrosc; 2024 Sep; ():. PubMed ID: 39228215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of venous thromboembolism prophylaxis with fondaparinux or low molecular weight heparin in a large cohort of consecutive patients undergoing major orthopaedic surgery - findings from the ORTHO-TEP registry.
    Donath L; Lützner J; Werth S; Kuhlisch E; Hartmann A; Günther KP; Weiss N; Beyer-Westendorf J
    Br J Clin Pharmacol; 2012 Dec; 74(6):947-58. PubMed ID: 22515679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence and risk factors associated with venous thromboembolism following primary total hip arthroplasty in low-risk patients when using aspirin for prophylaxis.
    Howard TA; Judd CS; Snowden GT; Lambert RJ; Clement ND
    Hip Int; 2022 Sep; 32(5):562-567. PubMed ID: 33594900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of 90-Day Adverse Events Associated With Aspirin and Potent Anticoagulation Use for Venous Thromboembolism Prophylaxis: A Cohort Study of 72,288 Total Knee and 35,142 Total Hip Arthroplasty Patients.
    Singh G; Prentice HA; Winston BA; Kroger EW
    J Arthroplasty; 2023 Aug; 38(8):1602-1612.e1. PubMed ID: 36805118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Venous thromboembolism rates in patients undergoing major hip and knee joint surgery at Waitemata District Health Board: a retrospective audit.
    Dixon J; Ahn E; Zhou L; Lim R; Simpson D; Merriman EG
    Intern Med J; 2015 Apr; 45(4):416-22. PubMed ID: 25644232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rivaroxaban for the prevention of venous thromboembolism: a single technology appraisal.
    Stevenson M; Scope A; Holmes M; Rees A; Kaltenthaler E
    Health Technol Assess; 2009 Oct; 13 Suppl 3():43-8. PubMed ID: 19846028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does the publication of NICE guidelines for venous thromboembolism chemical prophylaxis influence the prescribing patterns of UK hip and knee surgeons?
    Matharu GS; Blom AW; Board T; Whitehouse MR;
    Ann R Coll Surg Engl; 2022 Mar; 104(3):195-201. PubMed ID: 34825570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.